Thanks for the welcome, but I am confused by your response. It sounds like we both are saying the same thing: they looked at safety (reviewed all adverse events whatever they may be), and found that the trial should continue as planned. What did you want me to discover about the trial design, or what are you thinking I am fearing? Best of luck to you as well.

P.S. I am familiar with how clinical trials and DSMBs work as I have participated in several trials as an investigator, and have reviewed many trial protocols and DSMB charters in the last 10 years as a member of my institution's IRB.